Literature DB >> 24327607

Regulatory circuitry of TWEAK-Fn14 system and PGC-1α in skeletal muscle atrophy program.

Sajedah M Hindi1, Vivek Mishra, Shephali Bhatnagar, Marjan M Tajrishi, Yuji Ogura, Zhen Yan, Linda C Burkly, Timothy S Zheng, Ashok Kumar.   

Abstract

Skeletal muscle wasting attributed to inactivity has significant adverse functional consequences. Accumulating evidence suggests that peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) and TNF-like weak inducer of apoptosis (TWEAK)-Fn14 system are key regulators of skeletal muscle mass in various catabolic states. While the activation of TWEAK-Fn14 signaling causes muscle wasting, PGC-1α preserves muscle mass in several conditions, including functional denervation and aging. However, it remains unknown whether there is any regulatory interaction between PGC-1α and TWEAK-Fn14 system during muscle atrophy. Here we demonstrate that TWEAK significantly reduces the levels of PGC-1α and mitochondrial content (∼50%) in skeletal muscle. Levels of PGC-1α are significantly increased in skeletal muscle of TWEAK-knockout (KO) and Fn14-KO mice compared to wild-type mice on denervation. Transgenic (Tg) overexpression of PGC-1α inhibited progressive muscle wasting in TWEAK-Tg mice. PGC-1α inhibited the TWEAK-induced activation of NF-κB (∼50%) and dramatically reduced (∼90%) the expression of atrogenes such as MAFbx and MuRF1. Intriguingly, muscle-specific overexpression of PGC-1α also prevented the inducible expression of Fn14 in denervated skeletal muscle. Collectively, our study demonstrates that TWEAK induces muscle atrophy through repressing the levels of PGC-1α. Overexpression of PGC-1α not only blocks the TWEAK-induced atrophy program but also diminishes the expression of Fn14 in denervated skeletal muscle.

Entities:  

Keywords:  MAFBx; MuRF1; NF-κB; SP-1; denervation; mitochondria; ubiquitin-proteasome system

Mesh:

Substances:

Year:  2013        PMID: 24327607      PMCID: PMC3929677          DOI: 10.1096/fj.13-242123

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  53 in total

1.  Accumulation of severely atrophic myofibers marks the acceleration of sarcopenia in slow and fast twitch muscles.

Authors:  Sharon L Rowan; Fennigje M Purves-Smith; Nathan M Solbak; Russell T Hepple
Journal:  Exp Gerontol       Date:  2011-04-12       Impact factor: 4.032

Review 2.  Metabolic control through the PGC-1 family of transcription coactivators.

Authors:  Jiandie Lin; Christoph Handschin; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

3.  Mitochondrial DNA-deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibers.

Authors:  Entela Bua; Jody Johnson; Allen Herbst; Bridget Delong; Debbie McKenzie; Shahriar Salamat; Judd M Aiken
Journal:  Am J Hum Genet       Date:  2006-07-07       Impact factor: 11.025

4.  TWEAK attenuates the transition from innate to adaptive immunity.

Authors:  Heather Maecker; Eugene Varfolomeev; Frank Kischkel; David Lawrence; Heidi LeBlanc; Wyne Lee; Stephen Hurst; Dimitry Danilenko; Jun Li; Ellen Filvaroff; Becky Yang; Dylan Daniel; Avi Ashkenazi
Journal:  Cell       Date:  2005-12-02       Impact factor: 41.582

Review 5.  Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes.

Authors:  S T Smale
Journal:  Biochim Biophys Acta       Date:  1997-03-20

6.  The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms.

Authors:  Pradyut K Paul; Shephali Bhatnagar; Vivek Mishra; Sanjay Srivastava; Bryant G Darnay; Yongwon Choi; Ashok Kumar
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

7.  Skeletal muscle aging in F344BN F1-hybrid rats: I. Mitochondrial dysfunction contributes to the age-associated reduction in VO2max.

Authors:  Jason L Hagen; Daniel J Krause; David J Baker; Ming Hua Fu; Mark A Tarnopolsky; Russell T Hepple
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-11       Impact factor: 6.053

8.  Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation.

Authors:  Marc Uldry; Wenli Yang; Julie St-Pierre; Jiandie Lin; Patrick Seale; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2006-05       Impact factor: 27.287

9.  Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration.

Authors:  Foteini Mourkioti; Paschalis Kratsios; Tom Luedde; Yao-Hua Song; Patrick Delafontaine; Raffaella Adami; Valeria Parente; Roberto Bottinelli; Manolis Pasparakis; Nadia Rosenthal
Journal:  J Clin Invest       Date:  2006-11       Impact factor: 14.808

Review 10.  The TWEAK-Fn14 system: breaking the silence of cytokine-induced skeletal muscle wasting.

Authors:  S Bhatnagar; A Kumar
Journal:  Curr Mol Med       Date:  2012-01       Impact factor: 2.222

View more
  30 in total

Review 1.  The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting.

Authors:  James A Carson; Justin P Hardee; Brandon N VanderVeen
Journal:  Semin Cell Dev Biol       Date:  2015-12-01       Impact factor: 7.727

2.  The TWEAK-Fn14 dyad is involved in age-associated pathological changes in skeletal muscle.

Authors:  Marjan M Tajrishi; Shuichi Sato; Jonghyun Shin; Timothy S Zheng; Linda C Burkly; Ashok Kumar
Journal:  Biochem Biophys Res Commun       Date:  2014-03-26       Impact factor: 3.575

3.  Effect of denervation on the regulation of mitochondrial transcription factor A expression in skeletal muscle.

Authors:  Liam D Tryon; Matthew J Crilly; David A Hood
Journal:  Am J Physiol Cell Physiol       Date:  2015-06-10       Impact factor: 4.249

4.  The nuclear phosphatase SCP4 regulates FoxO transcription factors during muscle wasting in chronic kidney disease.

Authors:  Xinyan Liu; Rizhen Yu; Lijing Sun; Giacomo Garibotto; Xia Lin; Yanlin Wang; Sandhya S Thomas; Rongshan Li; Zhaoyong Hu
Journal:  Kidney Int       Date:  2017-05-12       Impact factor: 10.612

5.  Electrical stimulation prevents doxorubicin-induced atrophy and mitochondrial loss in cultured myotubes.

Authors:  Blas A Guigni; Dennis K Fix; Joseph J Bivona; Bradley M Palmer; James A Carson; Michael J Toth
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-18       Impact factor: 4.249

Review 6.  The TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and disease.

Authors:  Marjan M Tajrishi; Timothy S Zheng; Linda C Burkly; Ashok Kumar
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-24       Impact factor: 7.638

7.  Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction.

Authors:  Shuichi Sato; Yuji Ogura; Marjan M Tajrishi; Ashok Kumar
Journal:  FASEB J       Date:  2014-12-02       Impact factor: 5.191

8.  TWEAK/Fn14, a pathway and novel therapeutic target in myotonic dystrophy.

Authors:  Ramesh S Yadava; Erin P Foff; Qing Yu; Jordan T Gladman; Yun K Kim; Kirti S Bhatt; Charles A Thornton; Timothy S Zheng; Mani S Mahadevan
Journal:  Hum Mol Genet       Date:  2014-12-11       Impact factor: 6.150

9.  Inhibition of ER stress and unfolding protein response pathways causes skeletal muscle wasting during cancer cachexia.

Authors:  Kyle R Bohnert; Yann S Gallot; Shuichi Sato; Guangyan Xiong; Sajedah M Hindi; Ashok Kumar
Journal:  FASEB J       Date:  2016-05-20       Impact factor: 5.191

10.  Heightened TWEAK-NF-κB signaling and inflammation-associated fibrosis in paralyzed muscles of men with chronic spinal cord injury.

Authors:  Ceren Yarar-Fisher; C Scott Bickel; Neil A Kelly; Michael J Stec; Samuel T Windham; Amie B McLain; Robert A Oster; Marcas M Bamman
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-03-01       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.